Is Private Equity a Good Option for Younger Doctors?

The role of private equity (PE) in ophthalmology has shifted the practice landscape during the past 10 years. While proponents of PE investment tout the benefit of extra access to capital and resources, critics fear that these partnerships lead to a loss of autonomy and potential risk to patient care. In this episode, Drs. Dagny Zhu, Omar Shakir, and Ravi Parikh review the current published data about PE in ophthalmology and share their personal perspectives on its real-world impact on clinical practice.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.